Nasolacrimal Tract Obstruction Clinical Trial
Official title:
Single Dose Tranexamic Acid for Dacryocystorhinostomy
Single dose tranexamic acid (TA) before dacryocystorhinostomy (DCR) operation: a
prospective, double blind, placebo controlled study.
The study hypothesis: TA in DCR might reduce the intraoperative and postoperative bleeding
in DCR surgery, and might reduce the duration of the surgery.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention